정부/공공기관
임상시험센터
CRO
분석CRO/센트럴랩
유관기관/협회
정보서비스
해외 유관 기관
* CRO 게재 기준: CRO자율등록 기관
ClinicalTrials.gov에 등록된 정보를 기준으로 코로나-19(COVID-19) 관련 글로벌 임상시험 현황을 제공합니다.
전체 2550건이 검색되었습니다.
| No. | Status | Study Title | Conditions | Interventions | Phase | Sponsor/Collaborators | Funder Type | Number Enrolled | Sex | Age | Locations |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1031 | Withdrawn | MK-5475 in Participants With Hypoxemia Due to COVID-19 Pneumonia (MK-5475-009) | Hypoxemia | Drug: MK-5475 Drug: Placebo |
Phase 1 | Merck Sharp & Dohme Corp. | INDUSTRY | 0 | All | 18 Years ~ 80 Years | |
| 1030 | Recruiting | Monitoring of the Post-vaccination Immune Response to COVID-19 Among Hospital Staff | Vaccined Againt COVID-19 | Biological: Monitoring of the immune response | Not Applicable | University Hospital, Clermont-Ferrand | OTHER | 300 | All | 18 Years ~ 65 Years | Clermont-Ferrand University Hospital, Clermont-Ferrand, Aura, France |
| 1029 | Completed | Monitoring SOF/VEL in Treatment Naive, HCV Participants With Active Infection | Liver Diseases | Drug: Sofosbuvir/Velpatasvir (SOF/VEL) Other: Minimal Monitoring (MINMON) Strategy |
Phase 4 | AIDS Clinical Trials Group, National Institute of Allergy and Infectious Diseases (NIAID) | NETWORK | 400 | All | 18 Years | Alabama CRS (31788), Birmingham, Alabama, United States University of Southern California (1201), Los Angeles, California, United States UCLA CARE Center CRS (601), Los Angeles, California, United States Ucsd, Avrc Crs (701), San Diego, California, United States Ucsf Aids Crs (801), San Francisco, California, United States University of Colorado Hospital CRS (6101), Aurora, Colorado, United States Whitman Walker Health CRS (31791), Washington, District of Columbia, United States The Ponce de Leon Center CRS (5802), Atlanta, Georgia, United States Northwestern University CRS (2701), Chicago, Illinois, United States Rush Univ. Med. Ctr. ACTG CRS (2702), Chicago, Illinois, United States Johns Hopkins University CRS (201), Baltimore, Maryland, United States Massachusetts General Hospital (MGH) CRS (101), Boston, Massachusetts, United States Brigham and Women's Hosp. ACTG CRS (107), Boston, Massachusetts, United States Washington U CRS (2101), Saint Louis, Missouri, United States New Jersey Medical School Clinical Research Center CRS (31786), Newark, New Jersey, United States Weill Cornell Chelsea CRS (7804), New York, New York, United States Columbia Physicians and Surgeons CRS (30329), New York, New York, United States Weill Cornell Upton CRS (7803), New York, New York, United States University of Rochester Adult HIV Therapeutic Strategies Network CRS (31787), Rochester, New York, United States Unc Aids Crs (3201), Chapel Hill, North Carolina, United States Greensboro CRS (3203), Greensboro, North Carolina, United States Univ. of Cincinnati CRS (2401), Cincinnati, Ohio, United States Case CRS (2501), Cleveland, Ohio, United States The Ohio State Univ. AIDS CRS (2301), Columbus, Ohio, United States Hosp. of the Univ. of Pennsylvania CRS (6201), Philadelphia, Pennsylvania, United States Pittsburgh CRS (1001), Pittsburgh, Pennsylvania, United States The Miriam Hospital ACTG CRS (2951), Providence, Rhode Island, United States Vanderbilt Therapeutics (VT) CRS (3652), Nashville, Tennessee, United States Trinity Health and Wellness Center CRS (31443), Dallas, Texas, United States Houston AIDS Research Team CRS (31473), Houston, Texas, United States Hospital Nossa Senhora da Conceicao CRS (12201), Porto Alegre, RS, Brazil Instituto de Pesquisa Clinica Evandro Chagas (12101), Rio de Janeiro, Brazil Puerto Rico-AIDS CRS (5401), San Juan, Puerto Rico University of the Witwatersrand Helen Joseph (WITS HJH) CRS (11101), Johannesburg, Gauteng, South Africa Family Clinical Research Unit (FAM-CUR) CRS (8950), Cape Town, West Cape, South Africa Thai Red Cross AIDS Research Centre (TRC-ARC) CRS (31802), Bangkok, Patumwan, Thailand Chiang Mai University HIV Treatment CRS (31784), Chiang Mai, Thailand Joint Clinical Research Centre (JCRC) (12401), Kampala, Uganda |
| 1028 | Completed | Monovalent Recombinant COVID19 Vaccine | COVID | Biological: COVID19 vaccine Biological: Saline |
Phase 1 | Vaxine Pty Ltd, Central Adelaide Local Health Network Incorporated | INDUSTRY | 40 | All | 18 Years ~ 65 Years | PARC,, Adelaide, South Australia, Australia |
| 1027 | Recruiting | Morbi-mortality by COVID-19 Among Homeless People in Marseille: a Cohort Study | Homeless | Biological: Blood sample Biological: Blood sample |
Not Applicable | Assistance Publique Hopitaux De Marseille | OTHER | 2000 | All | 18 Years | Assistance Publique Hopitaux de Marseille, Marseille, Paca, France |
| 1026 | Recruiting | Mouth Rinses for Inactivation of COVID-19 | SARS-CoV-2 Infection | Drug: 1.5% w/v Hydrogen Peroxide Drug: 0.12% Chlorhexidine Gluconate Drug: 27% Ethanol plus essential oils Drug: 0.5% w/v Povidone-iodide Drug: 0.075% Cetylpyridinium Chloride Other: Saline |
Phase 2 | University of North Carolina, Chapel Hill | OTHER | 480 | All | 18 Years ~ 65 Years | General and Oral Health Center, Chapel Hill, North Carolina, United States |
| 1025 | Not yet recruiting | MP1032 Treatment in Patients With Moderate to Severe COVID-19 | COVID-19 | Drug: MP1032 Drug: Placebo |
Phase 2 | MetrioPharm AG, Syneos Health, LLC | INDUSTRY | 120 | All | 18 Years |
